• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非急性适应证经皮冠状动脉介入治疗比例下降程度的地区和医院差异——一项基于全国人口的研究

Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications - a nationwide population-based study.

作者信息

Liang Fu-Wen, Lu Tsung-Hsueh, Wu Hsin-Min, Lee Jo-Chi, Yin Wei-Hsian

机构信息

The NCKU Research Center for Health Data and Department of Public Health, National Cheng Kung University, No. 1, University Road, East District, Tainan, 70101, Taiwan.

Division of Cardiology, Cheng Hsin General Hospital, No. 45, Cheng Hsin Street, Bei-Tou, Taipei, 11220, Taiwan.

出版信息

BMC Cardiovasc Disord. 2017 Jun 9;17(1):149. doi: 10.1186/s12872-017-0592-4.

DOI:10.1186/s12872-017-0592-4
PMID:28599642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5466717/
Abstract

BACKGROUND

The volume and percentage of percutaneous coronary interventions (PCIs) performed for nonacute indications have declined in the United States since 2007. However, little is known if similar trends occurred in Taiwan.

METHODS

We used data from Taiwan National Health Insurance inpatient claims to examine the regional and hospital variations in the extent of decline in the percentage of nonacute indication PCIs from 2007 to 2012.

RESULTS

The volume of total PCIs persistently increased from 29,032 in 2007 to 35,811 in 2010 and 37,426 in 2012. However, the volume of nonacute indication PCIs first increased from 7916 in 2007 to 9143 in 2009 and then decreased to 8666 in 2012. The percentage of nonacute indication PCIs steadily decreased from 27% in 2007 to 26% in 2009 and then to 23% in 2012, a - 15% change. The extent of decline was largest in the North region (from 27% to 21%, a - 22% change) and least in Kaopin region (from 20% to 18%, a - 13% change). Of the 71 hospitals studied, 14 did not show a decreasing trend. Five of the 14 hospitals even showed an increasing trend, with a percentage change >10% between 2007 and 2012. In 2012, 6 hospitals had a nonacute indication PCI percentage >35%.

CONCLUSIONS

In Taiwan, four-fifths of the hospitals showed a decline in the percentage of nonacute indication PCIs from 2007 to 2012. It is plausible that Taiwanese cardiologists would have been influenced by the recommendations of crucial US trials and guidelines.

摘要

背景

自2007年以来,美国非急性适应症经皮冠状动脉介入治疗(PCI)的数量和百分比有所下降。然而,台湾是否出现类似趋势尚不清楚。

方法

我们使用台湾国民健康保险住院理赔数据,研究2007年至2012年非急性适应症PCI百分比下降程度的地区和医院差异。

结果

PCI总数持续增加,从2007年的29,032例增加到2010年的35,811例和2012年的37,426例。然而,非急性适应症PCI数量先从2007年的7916例增加到2009年的9143例,然后在2012年降至8666例。非急性适应症PCI的百分比从2007年的27%稳步下降到2009年的26%,然后在2012年降至23%,变化了-15%。下降幅度在北部地区最大(从27%降至21%,变化了-22%),在高雄地区最小(从20%降至1%,变化了-13%)。在研究的71家医院中,14家没有呈现下降趋势。这14家医院中有5家甚至呈现上升趋势,2007年至2012年期间百分比变化>10%。2012年,6家医院的非急性适应症PCI百分比>35%。

结论

在台湾,五分之四的医院在2007年至2012年期间非急性适应症PCI的百分比有所下降。台湾心脏病专家很可能受到了美国关键试验和指南建议的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1028/5466717/7b32766f6baa/12872_2017_592_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1028/5466717/416ba3b4f399/12872_2017_592_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1028/5466717/7b32766f6baa/12872_2017_592_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1028/5466717/416ba3b4f399/12872_2017_592_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1028/5466717/7b32766f6baa/12872_2017_592_Fig2_HTML.jpg

相似文献

1
Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications - a nationwide population-based study.非急性适应证经皮冠状动脉介入治疗比例下降程度的地区和医院差异——一项基于全国人口的研究
BMC Cardiovasc Disord. 2017 Jun 9;17(1):149. doi: 10.1186/s12872-017-0592-4.
2
Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001-2013.2001 - 2013年台湾未达经皮冠状动脉介入治疗最低手术量标准的医院及医疗机构比例变化趋势。
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):247-250. doi: 10.1002/ccd.27343. Epub 2017 Sep 30.
3
Variation in practice and concordance with guideline criteria for length of stay after elective percutaneous coronary intervention.择期经皮冠状动脉介入治疗后住院时间的实践差异及与指南标准的一致性
Catheter Cardiovasc Interv. 2017 Nov 1;90(5):715-722. doi: 10.1002/ccd.26992. Epub 2017 Mar 31.
4
The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.《从全国心血管数据注册中心经皮冠状动脉介入治疗(PCI)注册研究看出血预防策略对经皮冠状动脉介入治疗术后出血率的医院间差异的影响》
JACC Cardiovasc Interv. 2016 Apr 25;9(8):771-779. doi: 10.1016/j.jcin.2016.01.033.
5
Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry®.介入心脏病学领域的女性:来自美国国家心血管数据注册库®的经皮冠状动脉介入治疗实践模式及女性操作者结局的最新情况
Catheter Cardiovasc Interv. 2016 Mar;87(4):663-8. doi: 10.1002/ccd.26118. Epub 2015 Aug 10.
6
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.冠状动脉血运重建的合理使用标准以及经皮冠状动脉介入治疗的利用趋势、患者选择和适宜性
JAMA. 2015 Nov 17;314(19):2045-53. doi: 10.1001/jama.2015.13764.
7
Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.美国顶尖医院和非顶尖医院行经皮冠状动脉介入治疗的适宜性和结局。
JACC Cardiovasc Interv. 2018 Feb 26;11(4):342-350. doi: 10.1016/j.jcin.2017.10.042. Epub 2017 Nov 12.
8
Percutaneous coronary interventions for stable ischemic heart disease in Italy.意大利稳定型缺血性心脏病的经皮冠状动脉介入治疗。
J Cardiovasc Med (Hagerstown). 2019 Nov;20(11):762-767. doi: 10.2459/JCM.0000000000000835.
9
Appropriateness of percutaneous coronary intervention.经皮冠状动脉介入治疗的适宜性。
JAMA. 2011 Jul 6;306(1):53-61. doi: 10.1001/jama.2011.916.
10
Appropriateness of percutaneous coronary interventions in Washington State.华盛顿州经皮冠状动脉介入治疗的适宜性
Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):445-53. doi: 10.1161/CIRCOUTCOMES.111.964320. Epub 2012 May 8.

引用本文的文献

1
Incidence of cardiovascular diseases in a nationwide HIV/AIDS patient cohort in Taiwan from 2000 to 2014.2000 年至 2014 年台湾全国 HIV/AIDS 患者队列中心血管疾病的发病率。
Epidemiol Infect. 2018 Dec;146(16):2066-2071. doi: 10.1017/S0950268818002339. Epub 2018 Aug 30.

本文引用的文献

1
Trends in percutaneous coronary intervention and angiography in Ireland, 2004-2011: Implications for Ireland and Europe.2004 - 2011年爱尔兰经皮冠状动脉介入治疗与血管造影趋势:对爱尔兰和欧洲的启示
Int J Cardiol Heart Vessel. 2014 Aug 12;4:35-39. doi: 10.1016/j.ijchv.2014.08.001. eCollection 2014 Sep.
2
Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era.评估稳定型冠心病患者的风险:我们何时应加强护理和随访?对 COURAGE 和 FAME 时代观察性研究的荟萃分析结果
Scientifica (Cairo). 2016;2016:3769152. doi: 10.1155/2016/3769152. Epub 2016 Apr 27.
3
The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15years in a Taiwanese population.
台湾人群中急性心肌梗死的发病率、治疗情况及院内死亡率的15年时间趋势。
Int J Cardiol. 2016 Apr 15;209:103-13. doi: 10.1016/j.ijcard.2016.02.022. Epub 2016 Feb 3.
4
Characteristics of Early and Late Adopting Hospitals Providing Percutaneous Coronary Intervention in Taiwan.台湾地区早期和晚期采用经皮冠状动脉介入治疗医院的特征
J Am Heart Assoc. 2015 Dec 23;4(12):e002840. doi: 10.1161/JAHA.115.002840.
5
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.冠状动脉血运重建的合理使用标准以及经皮冠状动脉介入治疗的利用趋势、患者选择和适宜性
JAMA. 2015 Nov 17;314(19):2045-53. doi: 10.1001/jama.2015.13764.
6
Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of Korea.2006年至2010年韩国冠状动脉血运重建术的实践变化。
Yonsei Med J. 2015 Jul;56(4):895-903. doi: 10.3349/ymj.2015.56.4.895.
7
Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program.经皮冠状动脉介入治疗适宜性的时间趋势:来自临床结果评估计划的见解。
Circulation. 2015 Jul 7;132(1):20-6. doi: 10.1161/CIRCULATIONAHA.114.015156. Epub 2015 May 28.
8
Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions.COURAGE试验和BARI-2D试验后经皮冠状动脉介入治疗量的趋势:来自超过810万例经皮冠状动脉介入治疗的洞察
Int J Cardiol. 2015 Mar 15;183:6-10. doi: 10.1016/j.ijcard.2015.01.053. Epub 2015 Jan 27.
9
Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011).美国经皮冠状动脉介入治疗用于急性冠状动脉综合征和稳定型冠状动脉疾病的管理(2007 年至 2011 年)。
Am J Cardiol. 2014 Oct 1;114(7):1003-10. doi: 10.1016/j.amjcard.2014.07.013. Epub 2014 Jul 18.
10
Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.《利用血运重建和积极药物评估的临床结果》(COURAGE)试验发表后,稳定型缺血性心脏病经皮冠状动脉介入治疗的地理差异变化。
Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):125-30. doi: 10.1161/CIRCOUTCOMES.113.000282. Epub 2013 Dec 17.